
Keywords: Aβ; amyloid-β; AD; Alzheimer's disease; Ahx; aminohexanoic linker; EDC; 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; fAD; familial form of AD; GPI; glycophosphatidylinositol; HBSS; Hank's balanced salt solution; HFIP; hexafluoro-2-propanol; LDH; lacta